Antoun Toubaji Selected Research

Therapeutics

1/2022	Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype.
1/2022	Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
11/2012	Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: a tissue microarray and digital imaging analysis-based study of 428 cases.
2/2012	The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.
1/2011	Does valproic acid induce neuroendocrine differentiation in prostate cancer?
1/2010	A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma.
8/2009	Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy.
3/2009	TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antoun Toubaji Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 08/2007
7	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 05/2008
4	Disease Progression 01/2022 - 03/2009
3	Adenocarcinoma 10/2015 - 03/2009
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2022
2	Acinar Cell Carcinoma 10/2015 - 06/2011
2	Kidney Neoplasms (Kidney Cancer) 05/2014 - 08/2009
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2014 - 01/2010
2	Breast Neoplasms (Breast Cancer) 02/2012 - 08/2008
2	Prostatic Intraepithelial Neoplasia 08/2010 - 05/2008
1	Urachal adenocarcinoma 01/2022
1	Margins of Excision 11/2014
1	Leiomyomatosis 05/2014
1	Leiomyoma (Uterine Fibroids) 05/2014
1	Small Cell Carcinoma 06/2011
1	Medullary Carcinoma 08/2009
1	Seminoma 11/2008
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2008
1	Colorectal Neoplasms (Colorectal Cancer) 09/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2008
1	Carcinogenesis 05/2008
1	Inflammation (Inflammations) 05/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2015 - 08/2008
2	Biomarkers (Surrogate Marker)IBA 11/2012 - 04/2010
2	Androgen Receptors (Androgen Receptor)IBA 02/2012 - 08/2010
2	AndrogensIBA 02/2012 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 11/2008
2	Peptides (Polypeptides)IBA 01/2010 - 09/2008
2	Protein Subunit VaccinesIBA 09/2008 - 08/2007
2	VaccinesIBA 09/2008 - 08/2007
1	cabozantinibIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	LipidsIBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2014
1	Naphazoline (All Clear)FDA LinkGeneric 05/2014
1	Fumarate Hydratase (Fumarase)IBA 05/2014
1	FumaratesIBA 05/2014
1	SteroidsIBA 02/2012
1	Complementary DNA (cDNA)IBA 02/2012
1	Hormones (Hormone)IBA 02/2012
1	5-hydroxymethylcytosineIBA 08/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2011
1	SynaptophysinIBA 01/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2011
1	Chromogranin AIBA 01/2011
1	Protein Isoforms (Isoforms)IBA 08/2010
1	Serine Proteases (Serine Protease)IBA 08/2010
1	Cysteine-Rich Protein 61IBA 04/2010
1	IntegrinsIBA 04/2010
1	Monatide (IMS 3015)IBA 01/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2010
1	Cancer VaccinesIBA 01/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 08/2009
1	DeoxycytidineIBA 11/2008
1	Messenger RNA (mRNA)IBA 08/2008
1	COOH-terminal signal transamidaseIBA 08/2008
1	Polyamine OxidaseIBA 05/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008
1	EnzymesIBA 05/2008
1	PolyaminesIBA 05/2008
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2007
1	Therapeutic UsesIBA 08/2007
1	Interleukin-2 (IL2)IBA 08/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2009
6	Prostatectomy (Retropubic Prostatectomy) 12/2023 - 03/2009
1	Neoadjuvant Therapy 01/2022
1	Immunotherapy 09/2008